Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Tomoyo Kurisu"'
Autor:
Yuki Kyoda, Kohei Hashimoto, Atsushi Takahashi, Takeshi Maehana, Kimihito Tachikawa, Takashi Muranaka, Shuichi Kato, Tomoyo Kurisu, Fumimasa Fukuta, Takahiro Kirisawa, Manabu Okada, Ko Kobayashi, Toshiaki Tanaka, Shiro Hinotsu, Naoya Masumori
Publikováno v:
Current Urology, Vol 18, Iss 2, Pp 122-127 (2024)
Abstract. Background. We clarified the predictive factors for changes in the status of medications for lower urinary tract symptoms (LUTS) 2 years after local radiotherapy for nonmetastatic prostate cancer. Materials and methods. We retrospectively i
Externí odkaz:
https://doaj.org/article/9a93b65688f346b581eede6681656459
Autor:
Terufumi Kubo, Taro Sugawara, Tomoyo Shinkawa, Tomoyo Kurisu, Nodoka Kouzen, Toshiaki Tanaka, Fumimasa Fukuta, Kouji Yamasaki, Shintaro Sugita, Kazuhiko Matsuo, Rena Morita, Yoshihiko Hirohashi, Tomohide Tsukahara, Takayuki Kanaseki, Tadashi Hasegawa, Naoya Masumori, Toshihiko Torigoe
Publikováno v:
Immunological Medicine, Vol 44, Iss 2, Pp 136-141 (2021)
Effective management of immune-related adverse events in patients receiving immunotherapy for cancer is problematic. In this report, we present the case of a 58-year-old man with advanced clear cell renal cell carcinoma who responded well to a combin
Externí odkaz:
https://doaj.org/article/df76912d07174c658434da11e8f06dbd
Autor:
Yoshihiko Hirohashi, Taro Sugawara, Kazuhiko Matsuo, Toshihiko Torigoe, Tadashi Hasegawa, Nodoka Kouzen, Tomoyo Kurisu, Shintaro Sugita, Terufumi Kubo, Rena Morita, Toshiaki Tanaka, Takayuki Kanaseki, Tomohide Tsukahara, Naoya Masumori, Kouji Yamasaki, Fumimasa Fukuta, Tomoyo Shinkawa
Publikováno v:
Immunological Medicine, Vol 44, Iss 2, Pp 136-141 (2021)
Effective management of immune-related adverse events in patients receiving immunotherapy for cancer is problematic. In this report, we present the case of a 58-year-old man with advanced clear cell renal cell carcinoma who responded well to a combin
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 67(2)
We evaluated the impact of tumor shrinkage (TS) induced by molecular targeted therapy as the first-line systemic therapy on the survival of patients with metastatic renal cell carcinoma (mRCC). A total of 67 patients with mRCC who received first-line
Autor:
Tomoyo, Kurisu, Toshiaki, Tanaka, Manabu, Okada, Kouhei, Hashimoto, Kou, Kobayashi, Fumimasa, Fukuta, Eiji, Yoshida, Kouichi, Okuya, Ichiro, Takemasa, Naoya, Masumori
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 66(7)
A female septuagenarian had poorly controlled diabetes mellitus for more than 20 years. She had persistent pyuria, but did not seek further examination. In 2019, she was transported to our hospital by ambulance for sudden abdominal pain. Physical exa
Publikováno v:
Hinyokika kiyo. Acta urologica Japonica. 65(10)
A 72-year-old man was referred to our hospital for examination of a right adrenal tumor incidentally found by computed tomography for close inspection of lumbago. The computed tomography scan and magnetic resonance imaging showed a 51×54×43 mm soli